Expression de PD-L1 et inhibiteurs de la voie PD-1/PD-L1 dans le cancer du sein
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference108 articles.
1. Immune targeting in breast cancer;Cimino-Mathews;Oncol Williston Park N,2015
2. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers;Bertucci;Cancer Res,2006
3. Medullary carcinoma of the breast: a clinicopathologic study with 10-year follow-up;Ridolfi;Cancer,1977
4. Leukocyte composition of human breast cancer;Ruffell;Proc Natl Acad Sci U.S.A,2012
5. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014;Salgado;Ann Oncol,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axis;Cell Death & Disease;2023-02-01
2. PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance;Digestive and Liver Disease;2022-10
3. HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer;Bratislava Medical Journal;2022-07-23
4. Association of PD-1/PD-L1 expression and Epstein-–Barr virus infection in patients with invasive breast cancer;Diagnostic Pathology;2022-07-16
5. Small-molecule inhibitor PD-1/PD-L1 interaction for colorectal cancer treatment;Pharmaceutical Patent Analyst;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3